Amend 006 - Hepatitis A and B Adult and Pediatric - GlaxoSmithKline Inc.
Status Expired
Contract number E60PH-22HEAB/001/PH
Amendment value :
Solicitation number E60PH-22HEAB
Publication date
Contract award date
Last amendment date
Status Expired
Contract number E60PH-22HEAB/001/PH
Amendment value :
Solicitation number E60PH-22HEAB
Publication date
Contract award date
Last amendment date
The contract will be for a period of 48 month(s), from 2022/03/03 to 2026/03/31.
CAD 17,340,563.63
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below: